As life sciences organizations expand across borders and scale multi-site operations, the question of quality consistency grows increasingly complex. Ensuring that every facility operates under aligned standards, processes, and regulatory expectations is essential not only to maintain compliance but also to safeguard operational integrity and patient safety. This first part examines the rationale behind QMS harmonization, the strategic imperatives driving it, the organizational and technical challenges encountered along the way, and the added complexity introduced by navigating divergent regulatory landscapes such as those of the FDA and the European Union.